Precision Biosensor, Inc. (KOSDAQ:335810)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,732.00
-42.00 (-2.37%)
At close: Jun 5, 2026

Precision Biosensor Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4,2843,2911,7232,4267,5575,544
Short-Term Investments
7,2997,1362,0954,0901,09317,140
Cash & Short-Term Investments
11,58310,4273,8186,5178,65022,683
Cash Growth
231.99%173.11%-41.41%-24.66%-61.87%-5.38%
Accounts Receivable
2,9001,9981,7351,8211,6572,305
Other Receivables
579.29443.9683.29646.08332.68439.78
Receivables
3,9242,8853,1092,4671,9892,745
Inventory
8,6948,8748,9949,2349,6397,524
Prepaid Expenses
162.51158.87107.21108.06155.74212.39
Other Current Assets
512.64223.88342.33118.9336.03130.72
Total Current Assets
24,87622,56916,37118,44520,77133,295
Property, Plant & Equipment
25,01126,44530,83633,46927,80615,490
Long-Term Investments
1,5001,5001,5005,0005,0005,000
Other Intangible Assets
3,2711,8982,6763,2253,75924.16
Long-Term Deferred Tax Assets
---477.37370.25164
Other Long-Term Assets
632.54662.35656.591,171612.621,746
Total Assets
63,38153,07452,03962,47859,01055,718
Accounts Payable
700.8700.8545.06430.28769.13902.86
Accrued Expenses
1,1361,1461,172979.08585.07680.54
Short-Term Debt
4,1084,3835,9624,6448,113-
Current Portion of Long-Term Debt
7,5007,5006,0003,0003,000-
Current Portion of Leases
614.39691.72746.6703.94725.23104.41
Current Unearned Revenue
27.5226.09----
Other Current Liabilities
2,8723,1354,9663,5886,849463.86
Total Current Liabilities
16,95817,58319,39113,34520,0412,152
Long-Term Debt
1,5001,5004,37510,7863,0009,325
Long-Term Leases
522.12549.24579.311,1651,717222.34
Long-Term Unearned Revenue
16.0521.74----
Pension & Post-Retirement Benefits
727.49436.37579.59593.94646.15313.06
Other Long-Term Liabilities
134.79216.981,4164,560230.175,353
Total Liabilities
20,18220,30826,34130,45125,63417,365
Common Stock
10,9758,9795,8075,8075,7965,683
Additional Paid-In Capital
80,48472,29358,30157,59954,41553,224
Retained Earnings
-49,406-49,539-39,561-32,132-27,361-20,699
Comprehensive Income & Other
1,3561,0331,150753.8525.75145.8
Shareholders' Equity
43,20032,76725,69832,02733,37538,353
Total Liabilities & Equity
63,38153,07452,03962,47859,01055,718
Total Debt
14,24414,62417,66320,29916,5559,652
Net Cash (Debt)
-2,661-4,197-13,845-13,783-7,90413,032
Net Cash Growth
------43.30%
Net Cash Per Share
-183.78-332.53-1192.10-1187.80-685.771154.32
Filing Date Shares Outstanding
19.0117.9611.6111.6111.5911.37
Total Common Shares Outstanding
19.0117.9611.6111.6111.5911.37
Working Capital
7,9184,986-3,0215,099729.4631,143
Book Value Per Share
2272.061824.652212.542757.532879.323374.36
Tangible Book Value
31,83830,86923,02128,80329,61638,329
Tangible Book Value Per Share
1674.511718.961982.122479.872555.063372.23
Land
8,4559,0379,0379,0377,5422,723
Buildings
13,51213,51214,97414,9537,6857,685
Machinery
13,91813,63113,97310,70110,4127,655
Construction In Progress
76.5212.25111.352,7924,793764